Cytonics CYT-108: A Unique Approach to OA Treatment
In this interview, we spoke with Joey Bose, President & CEO of Cytonics, diving into the intricacies of their...
Clinical Trials
Master Protocols: FDA New Flexible Approach in Cancer Trials
Master Protocols (MPs) mark a significant evolution in the realm of clinical research, especially notable in oncology. These protocols,...
A Great Divide: Sponsors Clash With FDA on Trial Data Excess
A new study, conducted collaboratively by the Tufts Center for the Study of Drug Development (Tufts CSDD), the FDA,...
Clinical Trial GCP Focus: Powerful QA Strategies Revealed
One of the most well-received presentations from Momentum Events’ December 2023 2nd GCP Inspection Readiness Conference was Tony Johnson,...
FDA Unveils Groundbreaking Rare Disease Guidance Document
In a landmark move, the U.S. Food and Drug Administration (FDA) has released a detailed guidance document titled “Rare...
AI in Action: Medidata Focuses on Data Entry, Diverse Trials
Dive into the forefront of clinical trial innovation with our interview featuring Anthony Costello from Medidata. We discuss groundbreaking...
Shattering Myths FDA New Era of Diverse Healthcare Solutions
In an era marked by rapid advancements in healthcare, the importance of inclusivity and innovation in clinical trials and...
Metasite Mastery: Science 37 DCT Breakthrough
This interview features the innovative world of decentralized clinical trials (DCTs) with insights from Darcy Forman of Science 37....
myTomorrows Unveils New Patient Engagement Tactics with AI
Today we delve into the dynamic world of clinical trials. This discussion aims to uncover the intricacies and challenges...
Unlock Hidden Insights: Data Management Revolutionizes Clinical Trials
In today’s in-depth conversation, we delve into the evolving landscape of data management through EHR in clinical trials, focusing...